LogicBio Therapeutics, Inc. Operating Income
LogicBio Therapeutics, Inc. reported Operating Income of -$5.74 million for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2022-11-14
- LogicBio Therapeutics, Inc. operating income (loss) for the quarter ending 2022-09-30 was -$5.74M.
- LogicBio Therapeutics, Inc. operating income (loss) for the quarter ending 2022-06-30 was -$4.89M.
- LogicBio Therapeutics, Inc. operating income (loss) for the quarter ending 2022-03-31 was -$6.45M.
- LogicBio Therapeutics, Inc. operating income (loss) for the quarter ending 2021-12-31 was -$8.80M.
- LogicBio Therapeutics, Inc. operating income (loss) for fiscal 2021 was -$38.98M.
- LogicBio Therapeutics, Inc. operating income (loss) for fiscal 2020 was -$31.51M.
- LogicBio Therapeutics, Inc. operating income (loss) for fiscal 2019 was -$41.04M.
- LogicBio Therapeutics, Inc. operating income (loss) for fiscal 2018 was -$17.94M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2022-09-30 | -$5.74M 10-Q · filed 2022-11-14 | -$10.64M derived: sum of 2 quarters · filed 2022-11-14 | -$17.09M 10-Q · filed 2022-11-14 | -$25.89M derived: sum of 4 quarters · filed 2022-11-14 |
| 2022-06-30 | -$4.89M 10-Q · filed 2022-08-15 | -$11.34M 10-Q · filed 2022-08-15 | -$20.15M derived: sum of 3 quarters · filed 2022-08-15 | -$30.09M derived: sum of 4 quarters · filed 2022-11-14 |
| 2022-03-31 | -$6.45M 10-Q · filed 2022-05-16 | -$15.25M derived: sum of 2 quarters · filed 2022-05-16 | -$25.20M derived: sum of 3 quarters · filed 2022-11-14 | -$35.42M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-12-31 | -$8.80M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-04 | -$18.75M derived: sum of 2 quarters · filed 2022-11-14 | -$28.97M derived: sum of 3 quarters · filed 2022-11-14 | -$38.98M 10-K · filed 2022-03-04 |
| 2021-09-30 | -$9.94M 10-Q · filed 2022-11-14 | -$20.16M derived: sum of 2 quarters · filed 2022-11-14 | -$30.18M 10-Q · filed 2022-11-14 | -$36.62M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | -$10.22M 10-Q · filed 2022-08-15 | -$20.24M 10-Q · filed 2022-08-15 | -$26.68M derived: sum of 3 quarters · filed 2022-08-15 | -$34.45M derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | -$10.02M 10-Q · filed 2022-05-16 | -$16.46M derived: sum of 2 quarters · filed 2022-05-16 | -$24.23M derived: sum of 3 quarters · filed 2022-05-16 | -$32.18M derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | -$6.44M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-04 | -$14.21M derived: sum of 2 quarters · filed 2022-03-04 | -$22.17M derived: sum of 3 quarters · filed 2022-03-04 | -$31.51M 10-K · filed 2022-03-04 |
| 2020-09-30 | -$7.77M 10-Q · filed 2021-11-15 | -$15.72M derived: sum of 2 quarters · filed 2021-11-15 | -$25.07M 10-Q · filed 2021-11-15 | -$36.50M derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | -$7.96M 10-Q · filed 2021-08-09 | -$17.30M 10-Q · filed 2021-08-09 | -$28.73M derived: sum of 3 quarters · filed 2021-08-09 | -$39.77M derived: sum of 4 quarters · filed 2021-08-09 |
| 2020-03-31 | -$9.34M 10-Q · filed 2021-05-10 | -$20.78M derived: sum of 2 quarters · filed 2021-05-10 | -$31.81M derived: sum of 3 quarters · filed 2021-05-10 | -$42.27M derived: sum of 4 quarters · filed 2021-05-10 |
| 2019-12-31 | -$11.43M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | -$22.46M derived: sum of 2 quarters · filed 2021-03-15 | -$32.92M derived: sum of 3 quarters · filed 2021-03-15 | -$41.04M 10-K · filed 2021-03-15 |
| 2019-09-30 | -$11.03M 10-Q · filed 2020-11-09 | -$21.49M derived: sum of 2 quarters · filed 2020-11-09 | -$29.61M 10-Q · filed 2020-11-09 | -$36.99M derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | -$10.46M 10-Q · filed 2020-08-10 | -$18.58M 10-Q · filed 2020-08-10 | -$25.95M derived: sum of 3 quarters · filed 2020-08-10 | -$30.50M derived: sum of 4 quarters · filed 2020-08-10 |
| 2019-03-31 | -$8.12M 10-Q · filed 2020-05-11 | -$15.49M derived: sum of 2 quarters · filed 2020-05-11 | -$20.05M derived: sum of 3 quarters · filed 2020-05-11 | -$23.69M derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | -$7.38M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | -$11.93M derived: sum of 2 quarters · filed 2020-03-16 | -$15.57M derived: sum of 3 quarters · filed 2020-03-16 | -$17.94M 10-K · filed 2020-03-16 |
| 2018-09-30 | -$4.55M 10-Q · filed 2019-11-12 | -$8.19M derived: sum of 2 quarters · filed 2019-11-12 | -$10.57M 10-Q · filed 2019-11-12 | -$13.65M derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | -$3.64M 10-Q · filed 2019-08-13 | -$6.01M 10-Q · filed 2019-08-13 | -$9.10M derived: sum of 3 quarters · filed 2019-08-13 | -$10.15M derived: sum of 4 quarters · filed 2019-08-13 |
| 2018-03-31 | -$2.37M 10-Q · filed 2019-05-14 | -$5.46M derived: sum of 2 quarters · filed 2019-05-14 | -$6.51M derived: sum of 3 quarters · filed 2019-05-14 | |
| 2017-12-31 | -$3.08M derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | -$4.13M derived: sum of 2 quarters · filed 2019-04-01 | -$5.85M 10-K · filed 2019-04-01 | |
| 2017-09-30 | -$1.05M 10-Q · filed 2018-12-03 | -$2.77M 10-Q · filed 2018-12-03 |